View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsBhang 将来の成長Future 基準チェック /06現在、 Bhangの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Personal Products 収益成長33.2%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • Dec 01Third quarter 2022 earnings released: US$0.004 loss per share (vs US$0.003 loss in 3Q 2021)Third quarter 2022 results: US$0.004 loss per share (further deteriorated from US$0.003 loss in 3Q 2021). Revenue: US$363.1k (up 28% from 3Q 2021). Net loss: US$901.3k (loss widened 31% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Paul Pellegrini was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 27Bhang Inc. Announces Changes to Board of DirectorsBhang Inc. announced that Jessica Billingsley and Andrea L. Johnston have resigned from their respective positions as Directors of the Company. The Company is also announced that it has appointed Sara Lee Irwin and Paul Pellegrini to its Board of Directors. Ms. Irwin is a nationally recognized public voice on cannabis and cannabinoids for therapeutic use. With over decades of experience as both an industry consultant and chronic pain patient, Sara has leveraged her personal experience to become a leading representative and liaison working to bridge interests across multiple stakeholder groups, including patients, physicians, researchers, the pharmaceutical industry, investors, institutional brokers, and government. An early advocate of the benefits of the pharmaceutical application of cannabinoids, Ms. Irwin was the Director of Investor Relations at Cannasat Therapeutics between 2004 - 2010, an early-stage cannabinoid pharmaceutical company that, in 2006, became the first publicly traded herbal cannabis company in North America. Ms. Irwin was a founding director of Miraculo Inc., an integrated media, technology and consumer product company in the medical cannabis and CBD industry which was recently acquired by Trees Corporation, a premier Canadian cannabis retailer. Mr. Pellegrini is the Executive Chairman and Founder of Sussex Strategy Group. He brings a track record of proven success in strategic consulting based on direct government experience and his relationship-building expertise. In 1990, as President of HealthWatch, Mr. Pellegrini began providing strategic consulting services to clients in the public and private sectors on a wide variety of business, government relations and public affairs matters. Mr. Pellegrini's expertise in issues management, crisis communications, and stakeholder relations was called upon to serve in a variety of senior roles in federal and provincial ministerial offices. Subsequent to his tenure in the public sector, Mr. Pellegrini founded Sussex in 1998. Mr. Pellegrini currently serves on the Campaign Cabinet for the new Vaughan hospital and sits on the Board of Directors for CHAR Technologies. He is recognized as an active community leader advocating for numerous non-profit and charitable causes. Often interviewed for his insights into current government issues, Mr. Pellegrini has been a political commentator on CP24.Reported Earnings • Aug 30Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: US$300.3k (down 7.9% from 2Q 2021). Net loss: US$1.10m (loss widened 49% from 2Q 2021).お知らせ • Aug 11+ 1 more updateBhang Inc. Announces Executive ChangesBhang Inc. announced the resignation of CEO, Jamie L. Pearson, who has been with the Company since 2015 and has served as President of the brand since 2019. A nationwide search for Pearson's replacement is expected to begin shortly. In the meantime, Graham Simmonds will assume the role of interim CEO. Simmonds is also the Chairman of Plant-Based Investment Corp. In addition to holding multiple Board seats on Canadian-listed publicly traded companies, Simmonds is also an experienced CEO and entrepreneur.お知らせ • Jun 15Bhang Inc. Launches High Roller Nano-Infused Pre-RollBhang Inc. ('Bhang' or the 'Company') is complementing its strong position in the cannabis edibles market with the launch of a new, innovative pre-roll offering. The new Bhang High Roller Nano-infused Pre-Roll is a whole flower product combined with nano-THC that delivers a more effective, efficient, and consistent experience. Since 2010, the Company has focused on building a legacy around providing its customers with precise, consistent cannabis chocolate products, perfecting a recipe with Bhang's signature cannabis-free taste, and the best premium ingredients. Bhang High Roller Nano-infused Pre-Rolls add to the Company's legacy of effectiveness and consistency, produced with quality infused flower that is precisely dosed, just like Bhang's chocolates. The new infused pre-roll consists of hand-selected premium indoor flower combined with nano-THC coming in consistently at 50+% THC (20% more than their standard pre-roll), delivering a stronger and more enjoyable high. Nano-THC means the THC particles themselves are smaller, meaning the High Roller Pre-Roll is infused with tiny molecules making the THC easier to absorb, facilitating almost instant onset. The Bhang High Roller nano-infused pre-roll is available in 1 gram format, delivering a 50+% THC dosage carefully rolled in unbleached natural brown papers. The new product offering was mentioned in Bhang's recent Petalfast announcement and will be a significant part of the partnership kickoff, and is now ready to be sold in California dispensaries.Reported Earnings • Jun 02Full year 2021 earnings released: US$0.017 loss per share (vs US$0.032 loss in FY 2020)Full year 2021 results: US$0.017 loss per share (up from US$0.032 loss in FY 2020). Revenue: US$1.27m (down 22% from FY 2020). Net loss: US$3.30m (loss narrowed 25% from FY 2020).Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Chairman of Board Graham Simmonds was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Recent Insider Transactions Derivative • Jan 08Director exercised options to buy CA$80k worth of stock.On the 31st of December, Daniel Nauth exercised options to buy 937k shares at a strike price of around CA$0.077, costing a total of CA$72k. This transaction amounted to 180% of their direct individual holding at the time of the trade. Daniel currently holds less than 1% of total shares outstanding. Company insiders have collectively bought CA$137k more than they sold, via options and on-market transactions, in the last 12 months.お知らせ • Dec 19Bhang Inc. announced that it has received CAD 1.218107 million in fundingBhang Inc. announced a non-brokered private placement of 22,147,400 units at a price of CAD 0.055 per unit for gross proceeds of CAD 1,218,107 on December 17, 2021. Each unit consists of one subordinate voting common share and one half of common share purchase warrant. Each warrant can be exercised to acquire one common share at a price of CAD 0.1 per share for a period of 18 months from the date of closing. The securities are being subject to four months and one day hold period expiring on April 18, 2022. In connection with the transaction, the company paid, to a finder, a cash commission of approximately CAD 25,014 in relation to the gross proceeds of the transaction raised from subscribers introduced to the company by such finder. The company also issued an aggregate of 454,800 finder warrants to the finder with each finder warrant entitling the holder thereof to acquire one common share at an exercise price of CAD 0.10 for a period of 18 months following the closing of the transaction.Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$283.0k (up 7.4% from 3Q 2020). Net loss: US$688.5k (loss narrowed 47% from 3Q 2020). Revenue was in line with analyst estimates.Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$326.2k (up 3.4% from 2Q 2020). Net loss: US$736.2k (loss narrowed 34% from 2Q 2020).お知らせ • Mar 23Bhang Inc. announced that it has received CAD 1.770613 million in funding from Plant-Based Investment Corp. and other investorsOn March 22, 2021, Bhang Inc. (CNSX:BHNG) closed the transaction. The company issued 27,240,192 subordinate voting shares for gross proceeds of CAD 1,770,612 in the transaction. The company issued 16,853,615 subordinate voting shares for gross proceeds of CAD 1,095,485 in its second and final tranche. In connection with this tranche, the company paid, to certain eligible finders, a cash commission of approximately CAD 16,587 in relation to the gross proceeds raised from subscribers introduced to the company by such finders. The subordinate voting shares issued in connection with the second tranche are subject to a statutory four month and one day hold period expiring on July 23, 2021, and such further restrictions as may apply under foreign securities laws.お知らせ • Mar 07Bhang Inc. announced that it expects to receive CAD 2 million in funding from Plant-Based Investment Corp. and other investorsBhang Inc. (CNSX:BHNG) announced non-brokered private placement of 30,769,231 subordinate voting shares at a price of CAD 0.065 per share for gross proceeds of CAD 2,000,000 on March 5, 2021. On the same date, the company issued 10,386,577 subordinate voting shares for gross proceeds of CAD 675,128 in its first tranche. The tranche included participation from returning investor Plant-Based Investment Corp. (CNSX:PBIC) for 3,846,154 subordinate voting shares for CAD 250,000 to own 50.42% stake upon closing of first tranche. The shares issued are subject to hold period expiring on July 6, 2021.お知らせ • Jan 31Bhang Announces Board and Executive ChangesBhang Inc. announced that its board of directors has appointed Graham Simmonds as a director of the Company following the resignation of Nick J. Richards, effective January 28, 2021. Mr. Simmonds was also appointed as Executive Chair of the board of directors and Daniel Nauth, the Company's former Chairman, continues to serve as a director of the Company. Mr. Simmonds was nominated as a director by Plant-Based Investment Corp. ("PBIC") pursuant to a subscription agreement between the Company and PBIC dated February 10, 2020, whereby PBIC has the right to appoint a nominee to the Company's board of directors. Mr. Simmonds currently serves as Chair of PBIC and was formerly Executive Vice Chair of Bhang in 2020. Mr. Simmonds is an entrepreneur with a diverse background in consumer-driven businesses. He has founded and taken public three companies over the past 15 years in the gaming, cannabis and financial technology sectors. Mr. Simmonds has over 20 years of general experience in public company management and business development projects within the gaming, technology and other regulated sectors. He is also licensed and/or has previously been licensed/registered with a number of horse racing and gaming commissions in the United States and Canada. Mr. Simmonds is the founder and former Chairman and CEO of CordovaCann Corp., and DealNet Capital Corp. Graham currently serves as a director and/or officer to a number of public companies including Baymount Incorporated, Prime City One Capital Corp., Aion Therapeutic Inc. and Plant-Based Investment Corp. Mr. Simmonds also formerly served as a director and as Executive Vice Chair of the Company in 2020.お知らせ • Nov 25Bhang Inc. Announces Director ChangesBhang Inc. announced that at the annual and special meeting held on November 24, 2020, it has approved election of Andrea Johnston and Jessica Billingsley to serve as directors of the Company and to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. The Company announced that William J. Waggoner, did not stand for re-election as a director.お知らせ • Oct 11Bhang Announces Board ChangesBhang Inc. announced the Company's board of directors has accepted the resignation of Graham Simmonds and has appointed Nick J. Richards to fill the board vacancy. Mr. Richards was nominated as a director by Cannabis Growth Opportunity Corporation pursuant to a subscription agreement between the Company and CGOC dated February 10, 2020, whereby CGOC has the right to appoint a nominee to the Company's board of directors. Mr. Richards is a Partner in the tax and cannabis practice groups at Greenspoon Marder LLP. As a former IRS trial attorney, he represents individuals and businesses in tax audits and trials, M&A, managing tax debt, and he advises cannabis companies, both owners and investors, regarding tax and regulatory compliance matters. In addition, he is widely recognized as a leading cannabis industry attorney and has extensive experience in IRC Section 280E and BSA cash reporting requirements. Mr. Richards is also an adjunct professor of law, proud father, husband, and a founding director of CGOC.お知らせ • Aug 06An unknown buyer acquired 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel for CAD 0.32 million.An unknown buyer acquired 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel for CAD 0.32 million on July 30, 2020. Scott J. Van Rixel sold 0.02 million multiple voting shares at a price of CAD 14.75 per share. Scott J. Van Rixel now owns 0.01 million multiple voting shares of Bhang representing approximately 16.32% of that class on an undiluted and diluted basis. Scott J. Van Rixel also has post conversion beneficial ownership of 12.3 million subordinate voting shares of Bhang. An unknown buyer completed the acquisition of 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel on July 30, 2020. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Bhang は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測CNSX:BHNG - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/20221-5-2-2N/A6/30/20221-4-2-2N/A3/31/20221-4-2-2N/A12/31/20211-3-2-2N/A9/30/20211-2-2-2N/A6/30/20211-4-2-2N/A3/31/20211-4-2-2N/A12/31/20202-4-2-2N/A9/30/20202-6-2-2N/A6/30/20203-13-5-5N/A3/31/20204-14-5-5N/A12/31/20195-13-4-4N/A9/30/20195-11-6-6N/A6/30/20194-3-4-3N/A3/31/20193-1-4-3N/A12/31/20182-2-4-4N/A12/31/20172-100N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: BHNGの予測収益成長が 貯蓄率 ( 2.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: BHNGの収益がCanadian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: BHNGの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: BHNGの収益がCanadian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: BHNGの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: BHNGの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHousehold 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/07/06 03:05終値2024/04/08 00:00収益2022/09/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bhang Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.004 loss per share (vs US$0.003 loss in 3Q 2021)Third quarter 2022 results: US$0.004 loss per share (further deteriorated from US$0.003 loss in 3Q 2021). Revenue: US$363.1k (up 28% from 3Q 2021). Net loss: US$901.3k (loss widened 31% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Paul Pellegrini was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 27Bhang Inc. Announces Changes to Board of DirectorsBhang Inc. announced that Jessica Billingsley and Andrea L. Johnston have resigned from their respective positions as Directors of the Company. The Company is also announced that it has appointed Sara Lee Irwin and Paul Pellegrini to its Board of Directors. Ms. Irwin is a nationally recognized public voice on cannabis and cannabinoids for therapeutic use. With over decades of experience as both an industry consultant and chronic pain patient, Sara has leveraged her personal experience to become a leading representative and liaison working to bridge interests across multiple stakeholder groups, including patients, physicians, researchers, the pharmaceutical industry, investors, institutional brokers, and government. An early advocate of the benefits of the pharmaceutical application of cannabinoids, Ms. Irwin was the Director of Investor Relations at Cannasat Therapeutics between 2004 - 2010, an early-stage cannabinoid pharmaceutical company that, in 2006, became the first publicly traded herbal cannabis company in North America. Ms. Irwin was a founding director of Miraculo Inc., an integrated media, technology and consumer product company in the medical cannabis and CBD industry which was recently acquired by Trees Corporation, a premier Canadian cannabis retailer. Mr. Pellegrini is the Executive Chairman and Founder of Sussex Strategy Group. He brings a track record of proven success in strategic consulting based on direct government experience and his relationship-building expertise. In 1990, as President of HealthWatch, Mr. Pellegrini began providing strategic consulting services to clients in the public and private sectors on a wide variety of business, government relations and public affairs matters. Mr. Pellegrini's expertise in issues management, crisis communications, and stakeholder relations was called upon to serve in a variety of senior roles in federal and provincial ministerial offices. Subsequent to his tenure in the public sector, Mr. Pellegrini founded Sussex in 1998. Mr. Pellegrini currently serves on the Campaign Cabinet for the new Vaughan hospital and sits on the Board of Directors for CHAR Technologies. He is recognized as an active community leader advocating for numerous non-profit and charitable causes. Often interviewed for his insights into current government issues, Mr. Pellegrini has been a political commentator on CP24.
Reported Earnings • Aug 30Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: US$300.3k (down 7.9% from 2Q 2021). Net loss: US$1.10m (loss widened 49% from 2Q 2021).
お知らせ • Aug 11+ 1 more updateBhang Inc. Announces Executive ChangesBhang Inc. announced the resignation of CEO, Jamie L. Pearson, who has been with the Company since 2015 and has served as President of the brand since 2019. A nationwide search for Pearson's replacement is expected to begin shortly. In the meantime, Graham Simmonds will assume the role of interim CEO. Simmonds is also the Chairman of Plant-Based Investment Corp. In addition to holding multiple Board seats on Canadian-listed publicly traded companies, Simmonds is also an experienced CEO and entrepreneur.
お知らせ • Jun 15Bhang Inc. Launches High Roller Nano-Infused Pre-RollBhang Inc. ('Bhang' or the 'Company') is complementing its strong position in the cannabis edibles market with the launch of a new, innovative pre-roll offering. The new Bhang High Roller Nano-infused Pre-Roll is a whole flower product combined with nano-THC that delivers a more effective, efficient, and consistent experience. Since 2010, the Company has focused on building a legacy around providing its customers with precise, consistent cannabis chocolate products, perfecting a recipe with Bhang's signature cannabis-free taste, and the best premium ingredients. Bhang High Roller Nano-infused Pre-Rolls add to the Company's legacy of effectiveness and consistency, produced with quality infused flower that is precisely dosed, just like Bhang's chocolates. The new infused pre-roll consists of hand-selected premium indoor flower combined with nano-THC coming in consistently at 50+% THC (20% more than their standard pre-roll), delivering a stronger and more enjoyable high. Nano-THC means the THC particles themselves are smaller, meaning the High Roller Pre-Roll is infused with tiny molecules making the THC easier to absorb, facilitating almost instant onset. The Bhang High Roller nano-infused pre-roll is available in 1 gram format, delivering a 50+% THC dosage carefully rolled in unbleached natural brown papers. The new product offering was mentioned in Bhang's recent Petalfast announcement and will be a significant part of the partnership kickoff, and is now ready to be sold in California dispensaries.
Reported Earnings • Jun 02Full year 2021 earnings released: US$0.017 loss per share (vs US$0.032 loss in FY 2020)Full year 2021 results: US$0.017 loss per share (up from US$0.032 loss in FY 2020). Revenue: US$1.27m (down 22% from FY 2020). Net loss: US$3.30m (loss narrowed 25% from FY 2020).
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Executive Chairman of Board Graham Simmonds was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions Derivative • Jan 08Director exercised options to buy CA$80k worth of stock.On the 31st of December, Daniel Nauth exercised options to buy 937k shares at a strike price of around CA$0.077, costing a total of CA$72k. This transaction amounted to 180% of their direct individual holding at the time of the trade. Daniel currently holds less than 1% of total shares outstanding. Company insiders have collectively bought CA$137k more than they sold, via options and on-market transactions, in the last 12 months.
お知らせ • Dec 19Bhang Inc. announced that it has received CAD 1.218107 million in fundingBhang Inc. announced a non-brokered private placement of 22,147,400 units at a price of CAD 0.055 per unit for gross proceeds of CAD 1,218,107 on December 17, 2021. Each unit consists of one subordinate voting common share and one half of common share purchase warrant. Each warrant can be exercised to acquire one common share at a price of CAD 0.1 per share for a period of 18 months from the date of closing. The securities are being subject to four months and one day hold period expiring on April 18, 2022. In connection with the transaction, the company paid, to a finder, a cash commission of approximately CAD 25,014 in relation to the gross proceeds of the transaction raised from subscribers introduced to the company by such finder. The company also issued an aggregate of 454,800 finder warrants to the finder with each finder warrant entitling the holder thereof to acquire one common share at an exercise price of CAD 0.10 for a period of 18 months following the closing of the transaction.
Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$283.0k (up 7.4% from 3Q 2020). Net loss: US$688.5k (loss narrowed 47% from 3Q 2020). Revenue was in line with analyst estimates.
Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$326.2k (up 3.4% from 2Q 2020). Net loss: US$736.2k (loss narrowed 34% from 2Q 2020).
お知らせ • Mar 23Bhang Inc. announced that it has received CAD 1.770613 million in funding from Plant-Based Investment Corp. and other investorsOn March 22, 2021, Bhang Inc. (CNSX:BHNG) closed the transaction. The company issued 27,240,192 subordinate voting shares for gross proceeds of CAD 1,770,612 in the transaction. The company issued 16,853,615 subordinate voting shares for gross proceeds of CAD 1,095,485 in its second and final tranche. In connection with this tranche, the company paid, to certain eligible finders, a cash commission of approximately CAD 16,587 in relation to the gross proceeds raised from subscribers introduced to the company by such finders. The subordinate voting shares issued in connection with the second tranche are subject to a statutory four month and one day hold period expiring on July 23, 2021, and such further restrictions as may apply under foreign securities laws.
お知らせ • Mar 07Bhang Inc. announced that it expects to receive CAD 2 million in funding from Plant-Based Investment Corp. and other investorsBhang Inc. (CNSX:BHNG) announced non-brokered private placement of 30,769,231 subordinate voting shares at a price of CAD 0.065 per share for gross proceeds of CAD 2,000,000 on March 5, 2021. On the same date, the company issued 10,386,577 subordinate voting shares for gross proceeds of CAD 675,128 in its first tranche. The tranche included participation from returning investor Plant-Based Investment Corp. (CNSX:PBIC) for 3,846,154 subordinate voting shares for CAD 250,000 to own 50.42% stake upon closing of first tranche. The shares issued are subject to hold period expiring on July 6, 2021.
お知らせ • Jan 31Bhang Announces Board and Executive ChangesBhang Inc. announced that its board of directors has appointed Graham Simmonds as a director of the Company following the resignation of Nick J. Richards, effective January 28, 2021. Mr. Simmonds was also appointed as Executive Chair of the board of directors and Daniel Nauth, the Company's former Chairman, continues to serve as a director of the Company. Mr. Simmonds was nominated as a director by Plant-Based Investment Corp. ("PBIC") pursuant to a subscription agreement between the Company and PBIC dated February 10, 2020, whereby PBIC has the right to appoint a nominee to the Company's board of directors. Mr. Simmonds currently serves as Chair of PBIC and was formerly Executive Vice Chair of Bhang in 2020. Mr. Simmonds is an entrepreneur with a diverse background in consumer-driven businesses. He has founded and taken public three companies over the past 15 years in the gaming, cannabis and financial technology sectors. Mr. Simmonds has over 20 years of general experience in public company management and business development projects within the gaming, technology and other regulated sectors. He is also licensed and/or has previously been licensed/registered with a number of horse racing and gaming commissions in the United States and Canada. Mr. Simmonds is the founder and former Chairman and CEO of CordovaCann Corp., and DealNet Capital Corp. Graham currently serves as a director and/or officer to a number of public companies including Baymount Incorporated, Prime City One Capital Corp., Aion Therapeutic Inc. and Plant-Based Investment Corp. Mr. Simmonds also formerly served as a director and as Executive Vice Chair of the Company in 2020.
お知らせ • Nov 25Bhang Inc. Announces Director ChangesBhang Inc. announced that at the annual and special meeting held on November 24, 2020, it has approved election of Andrea Johnston and Jessica Billingsley to serve as directors of the Company and to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. The Company announced that William J. Waggoner, did not stand for re-election as a director.
お知らせ • Oct 11Bhang Announces Board ChangesBhang Inc. announced the Company's board of directors has accepted the resignation of Graham Simmonds and has appointed Nick J. Richards to fill the board vacancy. Mr. Richards was nominated as a director by Cannabis Growth Opportunity Corporation pursuant to a subscription agreement between the Company and CGOC dated February 10, 2020, whereby CGOC has the right to appoint a nominee to the Company's board of directors. Mr. Richards is a Partner in the tax and cannabis practice groups at Greenspoon Marder LLP. As a former IRS trial attorney, he represents individuals and businesses in tax audits and trials, M&A, managing tax debt, and he advises cannabis companies, both owners and investors, regarding tax and regulatory compliance matters. In addition, he is widely recognized as a leading cannabis industry attorney and has extensive experience in IRC Section 280E and BSA cash reporting requirements. Mr. Richards is also an adjunct professor of law, proud father, husband, and a founding director of CGOC.
お知らせ • Aug 06An unknown buyer acquired 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel for CAD 0.32 million.An unknown buyer acquired 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel for CAD 0.32 million on July 30, 2020. Scott J. Van Rixel sold 0.02 million multiple voting shares at a price of CAD 14.75 per share. Scott J. Van Rixel now owns 0.01 million multiple voting shares of Bhang representing approximately 16.32% of that class on an undiluted and diluted basis. Scott J. Van Rixel also has post conversion beneficial ownership of 12.3 million subordinate voting shares of Bhang. An unknown buyer completed the acquisition of 35.36% stake in Bhang Inc. (CNSX:BHNG) from Scott J. Van Rixel on July 30, 2020.